Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?
Traditional antibiotic dosing was not designed for today's escalating antibiotic resistance,
lack of novel antibiotics and growing complexity in patient populations. Dosing that ensures …
lack of novel antibiotics and growing complexity in patient populations. Dosing that ensures …
Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review
Cystic fibrosis affects several organs, predisposing patients to severe bacterial respiratory
infections, including those caused by methicillin-resistant Staphylococcus aureus. Cystic …
infections, including those caused by methicillin-resistant Staphylococcus aureus. Cystic …
Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung
KA Rodvold, WW Hope, SE Boyd - Current Opinion in Pharmacology, 2017 - Elsevier
Highlights•Bronchoalveolar lavage for determining epithelial lining fluid exposures of
antibiotics.•Discussion about conducting intrapulmonary pharmacokinetic studies in critically …
antibiotics.•Discussion about conducting intrapulmonary pharmacokinetic studies in critically …
[HTML][HTML] Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults
T Welte, M Kantecki, GG Stone, J Hammond - International journal of …, 2019 - Elsevier
Abstract Staphylococcus aureus (S. aureus), including methicillin-resistant S. aureus
(MRSA), is an important aetiological cause of community-acquired pneumonia (CAP) and …
(MRSA), is an important aetiological cause of community-acquired pneumonia (CAP) and …
Nosocomial infections and ventilator-associated pneumonia in cancer patients
JV Divatia, JG Pulinilkunnathil, SN Myatra - Oncologic Critical Care, 2020 - Springer
Nosocomial infections or healthcare-acquired infections are a common cause of increased
morbidity and mortality among hospitalized patients. Cancer patients are at an increased …
morbidity and mortality among hospitalized patients. Cancer patients are at an increased …
[HTML][HTML] Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia?
DA Sweeney, AC Kalil - Clinical Microbiology and Infection, 2019 - Elsevier
Background The increasing prevalence of ventilator-associated pneumonia (VAP) due to
either multidrug-resistant (MDR) organisms or infections with limited treatment options (ie …
either multidrug-resistant (MDR) organisms or infections with limited treatment options (ie …
Pharmacodynamics of aerosolized fosfomycin and amikacin against resistant clinical isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a hollow …
FB Sime, A Johnson, S Whalley… - Antimicrobial agents …, 2017 - Am Soc Microbiol
There has been a resurgence of interest in aerosolization of antibiotics for treatment of
patients with severe pneumonia caused by multidrug-resistant pathogens. A combination …
patients with severe pneumonia caused by multidrug-resistant pathogens. A combination …
Lung penetration and pneumococcal target binding of antibiotics in lower respiratory tract infection
PTN Nguyen, NV Le, HMN Dinh… - Current Medical …, 2022 - Taylor & Francis
Objectives To achieve the therapeutic effects, antibiotics must penetrate rapidly into infection
sites and bind to targets. This study reviewed updated knowledge on the ability of antibiotics …
sites and bind to targets. This study reviewed updated knowledge on the ability of antibiotics …
Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated …
O Pajot, C Burdet, C Couffignal… - Journal of …, 2015 - academic.oup.com
Objectives Despite recent advances, antibiotic therapy of ventilator-associated pneumonia
(VAP) in ICU patients is still challenging. We assessed the impact of imipenem and amikacin …
(VAP) in ICU patients is still challenging. We assessed the impact of imipenem and amikacin …
Evaluasi Penggunaan Terapi Antibiotik Empiris Terhadap Luaran Klinis Pasien Pneumonia Komunitas Rawat Inap
SAB Pangeran, MA Manggau… - Majalah Farmasi dan …, 2022 - journal.unhas.ac.id
Pneumonia komunitas merupakan penyakit infeksi pada parenkim paru-paru yang
mengancam jiwa sehingga dapat diberikan terapi antibiotik empiris. Penelitian ini bertujuan …
mengancam jiwa sehingga dapat diberikan terapi antibiotik empiris. Penelitian ini bertujuan …